Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization: ESSA Pharma, Inc. (EPIX)

ESSA Pharma, Inc. (EPIX) - corporate logo

ESSA Pharma Inc. (EPIX) focuses on developing precision treatments for gynecological tumors and prostate cancer through receptor modulation. This chart confirms a market valuation of EV/EBITDA at . The company is implementing digital robots and automated molecule screening to accelerate research. This is critical, as biotech behemoths seek to occupy vacant niches more quickly and monopolize the market through patient recruitment speeds.

EPIX ESSA Pharma: Enterprise Value to EBITDA Ratio in the range 07/04/2022 - 11/10/2026

essapharma.com - analytical breakdowns and key metrics (EPIX)

- stock price and consensus target price:
Stock Quotes ESSA Pharma|EPIX - Consensus Target
- company stock exchange capitalization indicators:
Market Value ESSA Pharma|EPIX - Total Enterprise Value
- book value of equity indicators:
Net Assets per Single Share ESSA Pharma|EPIX - Company Net Assets|Market Capitalization to Book Value Ratio essapharma.com|EPIX - Company Assets
- debt and liquidity data:
Debt to Equity ESSA Pharma Inc.|EPIX - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital ESSA Pharma|EPIX - Company Cumulative Debt|Debt to Book Capitalization Ratio ESSA Pharma|EPIX - Long-Term Debt Volume|Company Short-Term Debt ESSA Pharma|Quick Ratio essapharma.com
- business earnings and investment ratios data:
EPIX - Net Profit|Future Profit ESSA Pharma Inc.|EPIX - Company Value to Net Income|Future Price to Earnings ESSA Pharma|EPIX - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple ESSA Pharma|EPIX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) ESSA Pharma|EPIX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months essapharma.com|EPIX - Earnings per share increase in current year|Net earnings per share growth forecast for next year ESSA Pharma Inc.
Initial company analysis:EPIX (ESSA Pharma Inc)
Original product of essapharma.com

Portfolio managers evaluate the operating model of ESSA Pharma Inc. (EPIX) using the enterprise value-to-EBITDA ratio, which allows for the determination of the real price of assets accounting for the debt load. Analyzing the trend level of the company's EV/EBITDA amid strategic cost reductions and workforce optimization helps identify the risk of overpayment and assess liquidity stability when seeking a merger partner.

Analysis of competing companies

Merus Corp - Enterprise Value to EBITDA Ratio|IMMP - Enterprise Value to EBITDA Ratio|ANIX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA atossatherapeutics.com|contexttherapeutics.com (CNTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Mersana Therapeutics, Inc.|BCTX (BriaCell Therapeutics Corp) - EV/EBITDA Multiple|Company Value to EBITDA QT Imaging, Inc. QTI